1. Home
  2. RNST vs PCVX Comparison

RNST vs PCVX Comparison

Compare RNST & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RNST

Renasant Corporation

HOLD

Current Price

$36.34

Market Cap

3.3B

Sector

Finance

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$46.76

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNST
PCVX
Founded
1904
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
6.0B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
RNST
PCVX
Price
$36.34
$46.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
7
Target Price
$43.17
$101.67
AVG Volume (30 Days)
484.8K
1.5M
Earning Date
10-28-2025
11-04-2025
Dividend Yield
2.53%
N/A
EPS Growth
N/A
N/A
EPS
1.84
N/A
Revenue
$775,309,000.00
N/A
Revenue This Year
$43.37
N/A
Revenue Next Year
$13.13
N/A
P/E Ratio
$19.79
N/A
Revenue Growth
13.04
N/A
52 Week Low
$26.97
$27.66
52 Week High
$40.40
$94.60

Technical Indicators

Market Signals
Indicator
RNST
PCVX
Relative Strength Index (RSI) 62.21 51.97
Support Level $35.16 $43.78
Resistance Level $36.18 $48.11
Average True Range (ATR) 0.80 1.99
MACD 0.25 -0.49
Stochastic Oscillator 96.11 42.99

Price Performance

Historical Comparison
RNST
PCVX

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Share on Social Networks: